Applications of Microarrays and Biochips in Pharmacogenomics
The complete sequence of the human genome and subsequent intensive searches for polymorphic variations are providing the prerequisite markers necessary to facilitate elucidation of the genetic variability in drug responses. Improvements in the sensitivity and precision of DNA microarrays permit a detailed and accurate scrutiny of the human genome. These advances have the potential to significantly improve health care management by improving disease diagnosis and targeting molecular therapy. Pharmacogenetic approaches, in limited use today, will become an integral part of therapeutic monitoring and health management, permitting patient stratification in advance of treatments, with the potential to eliminate adverse drug reactions. In this chapter, the current state of biochip technology is discussed, and recent applications in the arena of clinic diagnostics are explored.
KeywordsAmpliChip biochips microarrays P450 pharmacogenetics
- 10.Lundkvist, J., and Jönsson, B. (2004) Pharmacoeconomics of adverse drug reactions. Fund. Clin. Pharmacol. 18, 275–280.Google Scholar
- 22.Wick, I., and Hardiman, G. (2005) Biochip platforms as functional genomics tools for drug discovery. Curr. Opin. Drug Discov. Dev. 8, 347–354.Google Scholar
- 25.Mahant, V., Kureshy, F., Vairavan, R., and Hardiman, G. (2003) The INFINITI system–an automated multiplexing microarray platform, in Microarray Methods and Applications, vol. 16 (G. Hardiman, ed.), DNA Press, Eagleville, PA, pp. 325–328.Google Scholar
- 26.Kim, P., Fu, Y.K.K., Mahant, V., Kureshy, F., Hardiman, G., and Corbeil, J. (2006) The next generation of automated microarray platform for a multiplexed CYP2D6 assay, in Biochips as Pathways to Discovery, vol. 6 (A. Carmen and G. Hardiman, eds.) Taylor and Francis, New York, pp. 97–108.CrossRefGoogle Scholar